Ischaemic stroke in a patient on sunitinib

Ischaemic stroke in a patient on sunitinib

Concerns have been raised about possible theoretical risk of thrombosis and bleeding with sunitinib (anti-vascular endothelial cell growth factor agent) therapy used for treatment of metastatic renal cell carcinoma. We present the first case of stroke in an older man with metastatic renal cell carci...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:BMJ case reports 2010, Vol.2010 (mar15 1), p.bcr0120091420-bcr0120091420
Hauptverfasser: Lonergan, Maire Therese, Kellehar, Feargal, McDermott, Raymond, Collins, Ronan
Format: Artikel
Sprache:eng
Schlagworte:
Blood pressure
Cancer therapies
Cell growth
Europe (West)
Growth factors
Hypertension
Hypothyroidism
Interferon
Ischemia
Kinases
Magnetic resonance imaging
Male
Metastasis
Patients
Stroke
Surveillance
Thyroid gland
Tumors
Unexpected Outcome (Positive or Negative) Including Adverse Drug Reactions
White
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Concerns have been raised about possible theoretical risk of thrombosis and bleeding with sunitinib (anti-vascular endothelial cell growth factor agent) therapy used for treatment of metastatic renal cell carcinoma. We present the first case of stroke in an older man with metastatic renal cell carcinoma, on sunitinib therapy.
ISSN:1757-790X
1757-790X
DOI:10.1136/bcr.01.2009.1420